Wolverine Asset Management’s Translational Development Acquisition Corp Warrants TDACW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-103,336
Closed -$12.4K 1927
2026
Q1
$12.4K Sell
103,336
-3,143
-3% -$719 ﹤0.01% 1415
2025
Q4
$33K Sell
106,479
-37,324
-26% -$12.2K ﹤0.01% 1325
2025
Q3
$41.7K Sell
143,803
-11,197
-7% -$3.03K ﹤0.01% 1215
2025
Q2
$38.8K Buy
+155,000
New +$32K ﹤0.01% 1241

Other funds holding TDACW

Wolverine Asset Management's TDACW Position: Q2 2026 in Review

Wolverine Asset Management sold out of Translational Development Acquisition Corp Warrants (TDACW) in Q2 2026, closing a stake of 103,336 shares — an estimated $12.4K sold.

Wolverine Asset Management first reported a position in TDACW in Q2 2025 and held it in 4 quarters. The position peaked at $41.7K in Q3 2025. 28 funds tracked by Wall St. Rank hold TDACW as of Q2 2026.

  • Wolverine Asset Management reported no remaining Translational Development Acquisition Corp Warrants position as of Q2 2026 after selling out during the quarter.
  • Wolverine Asset Management sold 103,336 Translational Development Acquisition Corp Warrants shares in Q2 2026, an estimated $12.4K.
  • Wolverine Asset Management first reported a position in Translational Development Acquisition Corp Warrants in Q2 2025 and held it in 4 quarters.
  • Wolverine Asset Management's Translational Development Acquisition Corp Warrants position peaked at $41.7K in Q3 2025.
  • 28 funds tracked by Wall St. Rank held Translational Development Acquisition Corp Warrants as of Q2 2026.

Based on Wolverine Asset Management's 13F filing for Q2 2026, filed 10 Aug 2026.